<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bian Y</submitter><funding>NEI NIH HHS</funding><pagination>S92-S97</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7904972</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(3S)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To describe a reversible syndrome of epiphora, functional punctal stenosis, and chronic pretarsal conjunctivitis associated with corticosteroid or corticosteroid-antibiotic eyedrop use.&lt;h4>Methods&lt;/h4>This is an Institutional Review Board-approved retrospective review of patients diagnosed with epiphora, punctal stenosis, and chronic conjunctivitis by a single surgeon (B.J.W.). These patients were subsequently invited to participate in a prospective study involving allergy skin patch testing for ophthalmic drops, common excipients, and active ingredients.&lt;h4>Results&lt;/h4>Thirteen patients received a diagnosis of punctal congestion syndrome. The average age was 63 years (range, 41-93) and 69.2% were female. Findings were bilateral in 61.5%. All had used preserved drops in the</pubmed_abstract><journal>Ophthalmic plastic and reconstructive surgery</journal><pubmed_title>Punctal Congestion Syndrome: A Reversible, Functional Punctal Stenosis Causing Epiphora in the Setting of Chronic Pretarsal Conjunctivitis.</pubmed_title><pmcid>PMC7904972</pmcid><funding_grant_id>P30 EY002162</funding_grant_id><pubmed_authors>Zemsky C</pubmed_authors><pubmed_authors>Belsito DV</pubmed_authors><pubmed_authors>Scofield-Kaplan SM</pubmed_authors><pubmed_authors>Ghadiali L</pubmed_authors><pubmed_authors>Bian Y</pubmed_authors><pubmed_authors>Dagi Glass LR</pubmed_authors><pubmed_authors>Campagnoli T</pubmed_authors><pubmed_authors>Sallee B</pubmed_authors><pubmed_authors>Winn BJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Punctal Congestion Syndrome: A Reversible, Functional Punctal Stenosis Causing Epiphora in the Setting of Chronic Pretarsal Conjunctivitis.</name><description>&lt;h4>Purpose&lt;/h4>To describe a reversible syndrome of epiphora, functional punctal stenosis, and chronic pretarsal conjunctivitis associated with corticosteroid or corticosteroid-antibiotic eyedrop use.&lt;h4>Methods&lt;/h4>This is an Institutional Review Board-approved retrospective review of patients diagnosed with epiphora, punctal stenosis, and chronic conjunctivitis by a single surgeon (B.J.W.). These patients were subsequently invited to participate in a prospective study involving allergy skin patch testing for ophthalmic drops, common excipients, and active ingredients.&lt;h4>Results&lt;/h4>Thirteen patients received a diagnosis of punctal congestion syndrome. The average age was 63 years (range, 41-93) and 69.2% were female. Findings were bilateral in 61.5%. All had used preserved drops in the</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May-Jun 01</publication><modification>2025-04-03T22:46:27.821Z</modification><creation>2022-02-11T13:37:40.331Z</creation></dates><accession>S-EPMC7904972</accession><cross_references><pubmed>32890120</pubmed><doi>10.1097/iop.0000000000001840</doi><doi>10.1097/IOP.0000000000001840</doi></cross_references></HashMap>